Cervical cancer is one of the most common malignant tumors in women’s gynecology, and there is still a chance to cure cervical cancer at the middle stage. Generally speaking, cervical cancer in the middle stage has not metastasized extensively yet. If the patient’s health condition allows, radical cervical cancer treatment is needed if the patient can undergo surgery. It includes total hysterectomy plus bilateral adnexal resection and pelvic lymph node dissection. After surgery, adjuvant radiotherapy and chemotherapy are usually needed to control the progression of the disease. If there is no recurrence for more than five years after surgery, clinical cure can be achieved. However, it does not mean that there is no recurrence in the future, but that the chance of recurrence may be much lower, which is clinically called cure. In the case of mid-stage cervical cancer, regular review is required after surgery, once every three months within two years after surgery. Regular review is important because this is also a chronic disease.